Clinical Trials on Duchenne Muscular Dystrophy in Japan
Total 1109 results
-
Nippon Shinyaku Co., Ltd.Active, not recruiting
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Kobe UniversityNobelpharma; Japan Medical AssociationUnknownMuscular Dystrophy, DuchenneJapan
-
National Center of Neurology and Psychiatry, JapanNippon Shinyaku Co., Ltd.Completed
-
National Center of Neurology and Psychiatry, JapanNippon Shinyaku Co., Ltd.Completed
-
Daiichi Sankyo Co., Ltd.Orphan Disease Treatment Institute Co., Ltd.Completed
-
Daiichi Sankyo Co., Ltd.Active, not recruitingDuchenne Muscular DystrophyJapan
-
Taiho Pharmaceutical Co., Ltd.RecruitingDuchenne Muscular DystrophyJapan
-
Suzuka HospitalNagoya UniversityUnknownCardiomyopathies | Duchenne Muscular DystrophyJapan
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Cooperative International Neuromuscular Research...United States Department of DefenseCompletedDuchenne Muscular Dystrophy | Becker Muscular Dystrophy | Limb Girdle Muscular DystrophyUnited States, Japan, Canada
-
Eli Lilly and CompanyTerminatedMuscular Dystrophy, DuchenneGermany, United States, Spain, Belgium, France, Italy, Taiwan, Netherlands, Turkey, Korea, Republic of, Argentina, Canada, Japan, Puerto Rico, Russian Federation, United Kingdom
-
NS Pharma, Inc.Nippon Shinyaku Co., Ltd.Active, not recruitingDuchenne Muscular DystrophyKorea, Republic of, Chile, Japan, China, United Kingdom, Netherlands, Spain, Norway, Russian Federation, Australia, Greece, Italy, New Zealand, Turkey, Mexico, Czechia, Canada
-
PfizerTerminatedDuchenne Muscular DystrophyUnited States, Canada, United Kingdom, Japan, Italy
-
Sarepta Therapeutics, Inc.Hoffmann-La RocheRecruitingDuchenne Muscular DystrophyBelgium, United States, Japan, Spain, Italy, United Kingdom
-
PfizerTerminatedDuchenne Muscular DystrophyUnited States, Australia, Canada, United Kingdom, Japan, Bulgaria, Italy, Poland
-
BioMarin PharmaceuticalNo longer availableDuchenne Muscular DystrophyUnited States, Germany, United Kingdom, Japan, Netherlands, France, Spain, Korea, Republic of, Italy, Belgium, Taiwan, Argentina, Australia, Bulgaria, Czechia, Israel, Norway, Poland, Russian Federation, Turkey
-
Sarepta Therapeutics, Inc.Hoffmann-La RocheActive, not recruitingDuchenne Muscular DystrophyUnited States, Japan, Taiwan, Belgium, Spain, Germany, Hong Kong, Italy, United Kingdom
-
GlaxoSmithKlineCompletedMuscular DystrophiesFrance, Denmark, Germany, Belgium, Spain, Turkey, Korea, Republic of, Brazil, Netherlands, Italy, Chile, Japan, Canada, Hungary, Russian Federation, Czechia, Poland, Norway, Argentina, Taiwan
-
PfizerActive, not recruitingDuchenne Muscular DystrophyUnited States, Spain, Belgium, Korea, Republic of, Taiwan, Canada, Australia, Germany, Japan, France, Italy, United Kingdom, Russian Federation, Israel, Switzerland
-
Hoffmann-La RocheCompletedDuchenne Muscular DystrophyUnited States, Belgium, Canada, Australia, Japan, France, Netherlands, Spain, Argentina, Germany, Italy, United Kingdom, Sweden
-
PTC TherapeuticsCompletedNervous System Diseases | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Muscular Diseases | Neuromuscular Diseases | Muscular Dystrophies | Muscular Disorders, Atrophic | Muscular Dystrophy, Duchenne | Musculoskeletal DiseaseUnited States, Taiwan, India, Korea, Republic of, Thailand, Australia, Brazil, Bulgaria, Canada, China, Hong Kong, Malaysia, Mexico, Poland, Puerto Rico, Russian Federation, Turkey, Japan
-
GlaxoSmithKlineTerminatedMuscular DystrophiesFrance, Bulgaria, Denmark, Germany, Belgium, Canada, Spain, Turkey, United Kingdom, Korea, Republic of, Brazil, Netherlands, Italy, Japan, Czech Republic, Chile, Israel, Hungary, Russian Federation, Australia, Poland, Norway, Argentina and more
-
Novartis PharmaceuticalsActive, not recruitingBiallelic RPE65 Mutation-associated Retinal DystrophyJapan
-
Kyoto University, Graduate School of MedicineNovartisUnknown
-
Tokyo Medical UniversityUnknownCentral Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein OcclusionJapan
-
Mie UniversityUnknownCentral Retinal Vein OcclusionJapan
-
Nagoya City UniversityNovartisCompletedBranch Retinal Vein OcclusionJapan
-
University of TokushimaMinistry of Health, Labour and Welfare, JapanUnknownLower Limb Spasticity After StrokeJapan
-
Tohoku UniversityCompletedHereditary Inclusion Body Myopathy | Nonaka MyopathyJapan
-
Santen Pharmaceutical Co., Ltd.CompletedMacular Edema Following Branch Retinal Vein OcclusionJapan, Korea, Republic of
-
Mie UniversityUnknownExudative Age-related Macular DegenerationJapan
-
TakedaRecruitingSpinal and Bulbar Muscular AtrophyJapan
-
Santen Pharmaceutical Co., Ltd.CompletedDiabetic Macular EdemaJapan
-
Daiichi Sankyo Co., Ltd.CompletedFibrodysplasia Ossificans ProgressivaJapan
-
Kyoto University, Graduate School of MedicineKyoto Prefectural University of MedicineWithdrawnHypertension | Cardiovascular Disease | Vascular DiseaseJapan
-
Kyowa Kirin Co., Ltd.TerminatedHealthy Volunteers | Wet Age-related Macular DegenerationJapan
-
NovartisCompleted
-
Kyoto University, Graduate School of MedicineRecruiting
-
Nagoya City UniversityNovartisCompletedNeovascular Age-related Macular DegenerationJapan
-
Kumamoto UniversityCompletedAge-related Macular DegenerationJapan
-
Boehringer IngelheimRecruiting
-
Kagawa UniversityNovartis PharmaceuticalsCompleted
-
Showa UniversityCompletedto Compare the Effect of Two Types of IOLs | on the Incidence of Cystoid Macular Edema | After Cataract SurgeryJapan
-
Cook Group IncorporatedCompleted
-
SanofiCompletedPeripheral Arterial Disease (PAD)Japan
-
Johnson & Johnson K.K. Medical CompanyCompletedPeripheral Vascular DiseasesJapan
-
Kyorin UniversityCompleted
-
Translational Research Center for Medical Innovation...Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan; Kobe City...CompletedIschemia | Ulcer | Peripheral Vascular Diseases | Gangrene | Leg PainJapan
-
NovartisCompleted